Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.270
-0.070 (-5.22%)
At close: Apr 1, 2025, 4:00 PM
1.261
-0.009 (-0.73%)
After-hours: Apr 1, 2025, 4:02 PM EDT
SONN Market Cap
SONN has a market cap or net worth of $3.89 million as of April 1, 2025. Its market cap has decreased by -37.21% in one year.
Market Cap
3.89M
Enterprise Value
-642.51K
1-Year Change
-37.21%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since April 2, 2020, SONN's market cap has decreased from $58.10M to $3.89M, a decrease of -93.30%. That is a compound annual growth rate of -41.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 3.89M | -11.33% |
| Dec 31, 2024 | 4.39M | -17.79% |
| Dec 29, 2023 | 5.34M | -41.46% |
| Dec 30, 2022 | 9.12M | -63.34% |
| Dec 31, 2021 | 24.89M | -35.01% |
| Dec 31, 2020 | 38.30M | -34.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.32B |
| UnitedHealth Group | 480.42B |
| Johnson & Johnson | 399.99B |
| AbbVie | 367.50B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 229.49B |
| AstraZeneca | 229.16B |
| Merck & Co. | 225.47B |